• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原黄素与人α-凝血酶催化位点相邻的纤维蛋白肽凹槽内的结合。

Proflavin binding within the fibrinopeptide groove adjacent to the catalytic site of human alpha-thrombin.

作者信息

Sonder S A, Fenton J W

出版信息

Biochemistry. 1984 Apr 10;23(8):1818-23. doi: 10.1021/bi00303a037.

DOI:10.1021/bi00303a037
PMID:6722124
Abstract

Human alpha-thrombin with high fibrinogen-clotting activity binds proflavin at a single specific site (n = 0.996 site/alpha-thrombin, Kd = 22.0 microM) with the same affinity as the bovine enzyme (Kd = 22 +/- 3 vs. 24 +/- 3 microM, respectively, at pH 7.4, approximately 23 degrees C). This human enzyme form further displayed no significant difference in its ability to bind the dye over a broad NaCl concentration range (0.15-3 microM), and its hydrolysis of Bz-Arg-OEt was inhibited by the dye in a simple competitive manner (Ki = 30 +/- 3 microM). Conversion of the human alpha- to gamma-thrombin by controlled tryptic digestion essentially destroyed clotting activity without appreciably altering synthetic substrate activities and caused only approximately 2-fold reduction in proflavin binding. Chemical modification of approximately four tryptophans or approximately four tyrosines per enzyme also caused analogous differential losses of clotting vs. synthetic substrate activities and reduced proflavin binding approximately 5- and approximately 10-fold, respectively. Inactivation of the enzyme by conjugation at the catalytic serine (Ser-195, chymotrypsin numbering) with MeSO2 -F, PhMeSO2 -F, or i- Pr2P -F decreased binding approximately 4-, 26-, and 55-fold, respectively, following the increasing size and steric hindrance properties of the conjugated group. Conjugation of the catalytic histidine (His-57) with Tos-Lys-CH2-Cl decreased binding only approximately 10-fold, suggesting partial displacement by the dye. Such partial displacement appeared to occur to a slightly greater extent with the conjugate of a large exo site affinity-labeling reagent, which covalently attaches to the enzyme within the fibrino-peptide groove distal to the catalytic site.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

具有高纤维蛋白原凝血活性的人α-凝血酶在单个特定位点结合原黄素(n = 0.996个位点/α-凝血酶,Kd = 22.0微摩尔),其亲和力与牛酶相同(在pH 7.4、约23℃时,Kd分别为22±3和24±3微摩尔)。这种人酶形式在较宽的NaCl浓度范围(0.15 - 3微摩尔)内结合染料的能力没有显著差异,并且其对Bz-Arg-OEt的水解被染料以简单的竞争性方式抑制(Ki = 30±3微摩尔)。通过可控的胰蛋白酶消化将人α-凝血酶转化为γ-凝血酶基本上破坏了凝血活性,而没有明显改变合成底物活性,并且仅使原黄素结合减少约2倍。每个酶大约四个色氨酸或大约四个酪氨酸的化学修饰也分别导致凝血活性与合成底物活性的类似差异丧失,并使原黄素结合分别减少约5倍和约10倍。通过与MeSO2 -F、PhMeSO2 -F或i- Pr2P -F在催化丝氨酸(Ser-195,胰凝乳蛋白酶编号)处缀合使酶失活,随着缀合基团尺寸和空间位阻性质的增加,结合分别减少约4倍、26倍和55倍。催化组氨酸(His-57)与Tos-Lys-CH2-Cl缀合仅使结合减少约10倍,表明染料有部分取代。这种部分取代在与大的外位点亲和标记试剂的缀合物中似乎发生得稍多一些,该试剂在催化位点远端的纤维蛋白肽凹槽内与酶共价连接。(摘要截短至250字)

相似文献

1
Proflavin binding within the fibrinopeptide groove adjacent to the catalytic site of human alpha-thrombin.原黄素与人α-凝血酶催化位点相邻的纤维蛋白肽凹槽内的结合。
Biochemistry. 1984 Apr 10;23(8):1818-23. doi: 10.1021/bi00303a037.
2
Clotting of bovine fibrinogen. Kinetic analysis of the release of fibrinopeptides by thrombin and of the calcium uptake upon clotting at high fibrinogen concentrations.牛纤维蛋白原的凝血作用。在高纤维蛋白原浓度下,凝血酶释放纤维蛋白肽及凝血时钙摄取的动力学分析。
Biochemistry. 1988 Feb 9;27(3):976-82. doi: 10.1021/bi00403a021.
3
Changes in pH associated with clotting of fibrinogen. Kinetic studies of the pH shift and correlation of the pH change with the release of fibrinopeptides and the ensuing polymerization.与纤维蛋白原凝血相关的pH值变化。pH值变化的动力学研究以及pH值变化与纤维蛋白肽释放及随后聚合反应的相关性。
Biochemistry. 1991 May 14;30(19):4753-62. doi: 10.1021/bi00233a017.
4
Release of fibrinopeptides by the slow and fast forms of thrombin.凝血酶的慢速和快速形式释放纤维蛋白肽。
Biochemistry. 1996 Apr 9;35(14):4417-26. doi: 10.1021/bi952834d.
5
A synthetic analog of fibrinogen alpha 27-50 is an inhibitor of thrombin.纤维蛋白原α27 - 50的合成类似物是凝血酶的一种抑制剂。
Thromb Haemost. 1991 Feb 12;65(2):165-8.
6
The role of thrombin's Tyr-Pro-Pro-Trp motif in the interaction with fibrinogen, thrombomodulin, protein C, antithrombin III, and the Kunitz inhibitors.凝血酶的酪氨酸-脯氨酸-脯氨酸-色氨酸基序在与纤维蛋白原、血栓调节蛋白、蛋白C、抗凝血酶III及库尼兹抑制剂相互作用中的作用
J Biol Chem. 1993 Sep 5;268(25):19055-61.
7
Human alpha- to zeta-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retained.人α至ζ凝血酶的裂解在中性粒细胞组织蛋白酶G或胰凝乳蛋白酶作用下发生,同时纤维蛋白原的凝血活性得以保留。
Biochemistry. 1990 Apr 10;29(14):3536-42. doi: 10.1021/bi00466a017.
8
Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.纤溶酶消化纤维蛋白原过程中具有不同凝血酶结合特性的片段E形式的产生。
Biochem J. 1992 Feb 1;281 ( Pt 3)(Pt 3):613-8. doi: 10.1042/bj2810613.
9
Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.在纤维蛋白肽A中用酪氨酸取代苯丙氨酸会导致凝血酶从纤维蛋白原中优先切割纤维蛋白肽B。
Biochemistry. 1998 Sep 29;37(39):13704-9. doi: 10.1021/bi981190h.
10
A thrombin assay based upon the release of fibrinopeptide A from fibrinogen: definition of a new thrombin unit.一种基于从纤维蛋白原释放纤维蛋白肽A的凝血酶测定法:一种新的凝血酶单位的定义。
Thromb Res. 1984 Jul 15;35(2):111-20. doi: 10.1016/0049-3848(84)90206-8.

引用本文的文献

1
The N-terminal thrombin receptor fragment SFLLRN, but not catalytically inactive thrombin-derived agonists, activate U937 human monocytic cells: evidence for receptor hydrolysis in thrombin-dependent signalling.N 端凝血酶受体片段 SFLLRN 可激活 U937 人单核细胞,而催化失活的凝血酶衍生激动剂则不能:这是凝血酶依赖性信号传导中受体水解的证据。
Biochem J. 1993 Mar 1;290 ( Pt 2)(Pt 2):571-7. doi: 10.1042/bj2900571.
2
Evaluation of inhibitor constants and alkylation rates for a series of thrombin affinity labels.一系列凝血酶亲和标记物的抑制剂常数和烷基化速率评估
Biochem J. 1985 Sep 15;230(3):645-50. doi: 10.1042/bj2300645.
3
Self-regulation of procoagulant events on the endothelial cell surface.
内皮细胞表面促凝血事件的自我调节。
J Exp Med. 1985 Oct 1;162(4):1223-35. doi: 10.1084/jem.162.4.1223.
4
The structures and proteolytic specificities of autolysed human thrombin.自溶人凝血酶的结构与蛋白水解特异性
Biochem J. 1986 Dec 15;240(3):797-802. doi: 10.1042/bj2400797.
5
The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.人α-凝血酶的精细1.9埃晶体结构:与D-苯丙氨酸-脯氨酸-精氨酸氯甲基酮的相互作用以及酪氨酸-脯氨酸-脯氨酸-色氨酸插入片段的意义
EMBO J. 1989 Nov;8(11):3467-75. doi: 10.1002/j.1460-2075.1989.tb08511.x.
6
An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.一种针对该酶催化中心的获得性抗凝血酶自身抗体。
J Clin Invest. 1991 Jul;88(1):290-6. doi: 10.1172/JCI115290.
7
Hirulog-1 and -B2 thrombin specificity.水蛭素-1和-B2的凝血酶特异性。
Biochem J. 1992 Oct 15;287 ( Pt 2)(Pt 2):663-4. doi: 10.1042/bj2870663.
8
The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.D-苯丙氨酸-脯氨酸-精氨酸氯甲基酮抑制的人α-凝血酶的精制1.9埃X射线晶体结构:结构分析、整体结构、静电性质、详细的活性位点几何结构及结构-功能关系
Protein Sci. 1992 Apr;1(4):426-71. doi: 10.1002/pro.5560010402.